Monday, December 23, 2024
HomeTagsRegulatory Opportunities

Regulatory Opportunities

MedMira Announces VYRA CoV2Flu and Additional Regulatory Opportunities

MedMira Inc. announces the expansion of its VYRA product line by launching its VYRA CoV2Flu Rapid Antigen Rapid Test (VYRA™ CoV2Flu). Based on MedMira’s...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics